V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220001839 | 220008373 | null | null | null | 2016-08-02 | 2016-08-09 | null | 02 | null | CNS VINILO (TRIAL) WEEKLY VINBLASTINE | 100983792 |
| 220001846 | 220008378 | null | null | null | null | 2018-07-13 | CNS LGG Vinblastine | null | null | CNS LGG 2004 03 VINC WEEKLY+ CARBO | 100244512 |
| 220001849 | 220008379 | 1.8 | 110 | null | 2016-06-13 | 2016-06-13 | CNS PNET 5 Medbl L/StRsk Mnt A Cis | null | null | DABRAFENIB | 100646055 |
| 220001855 | 220008383 | null | null | Adjuvant (A) | 2017-10-27 | 2017-11-10 | null | N | Y | LOMUSTINE + PROCARBAZINE + VINCRISTINE | 100286070 |
| 220001865 | 220008389 | null | null | null | null | 2018-02-27 | CNS Low Grade Glioma Vinblastine | null | null | CARBOPLATIN + ETOPOSIDE | 100361338 |
| 220001868 | 220008392 | 1.77 | 119.8 | Palliative (P) | 2016-03-24 | 2016-03-27 | Trial Unspecified | 02 | N | TEMOZOLOMIDE + RT | 101704010 |
| 220001870 | 220008393 | 1.84 | 64.1 | Palliative (P) | 2018-05-19 | 2018-06-16 | Temozolomide + RT | 02 | N | TEMOZOLOMIDE + RT | 101106048 |
| 220001887 | 220008403 | null | null | null | null | 2017-11-17 | Lomustine | null | null | NOT MATCHED | 100623507 |
| 220001907 | 220008415 | 1.69 | 68.1 | Palliative (P) | 2018-02-14 | 2018-05-14 | null | 02 | N | TEMOZOLOMIDE + RT | 101179424 |
| 220001911 | 220008416 | null | null | null | null | 2018-11-08 | null | null | null | LOMUSTINE + PROCARBAZINE + VINCRISTINE | 101793547 |
| 220001930 | 220008428 | null | null | null | null | 2016-05-07 | Temozolomide + RT | null | null | VINBLASTINE | 101279807 |
| 220001938 | 220008431 | 1.61 | 66.7 | null | null | 2019-02-14 | null | null | null | DABRAFENIB + TRAMETINIB | 100703222 |
| 220001963 | 220008440 | 1.68 | 78.3 | null | 2017-11-26 | 2017-11-26 | null | N | null | LOMUSTINE + PROCARBAZINE + VINCRISTINE | 100648272 |
| 220001965 | 220008441 | 1.87 | 84 | null | null | 2020-07-15 | Temozolomide + RT | null | null | CNS INFANT HGG VINCRISTINE/CYCLOPHOSPHAMIDE | 100972424 |
| 220001966 | 220008442 | 1.88 | 69.7 | null | null | 2020-05-04 | null | null | null | CNS LGG 2004 03 VINC WEEKLY+ CARBO | 100829575 |
| 220001972 | 220008444 | 1.7 | 53.7 | null | null | 2020-07-01 | PCV | null | null | STS RHABDOMYOSARCOMA RMS 2005 IVA | 100869392 |
| 220001975 | 220008446 | null | null | null | null | 2018-12-12 | null | null | null | LOMUSTINE | 100494364 |
| 220001980 | 220008448 | null | null | Palliative (P) | 2020-08-11 | 2020-08-22 | Temozolomide + RT | 02 | N | TEMOZOLOMIDE + RT | 100542253 |
| 220001999 | 220008453 | null | null | null | null | 2016-04-05 | Lomustine | null | null | CARBOPLATIN + VINCRISTINE | 101827079 |
| 220002015 | 220008459 | null | null | null | null | 2018-03-06 | Epirubicin (weekly) | null | null | CNS LGG 2004 03 VINC WEEKLY+ CARBO | 101028150 |
| 220002024 | 220008465 | 1.5 | 99.2 | Curative (C) | 2020-09-28 | 2020-09-28 | null | 02 | N | TEMOZOLOMIDE + RT | 101555291 |
| 220002031 | 220008466 | null | null | Adjuvant (A) | 2019-06-08 | 2019-09-23 | Temozolomide + RT | 02 | Y | TEMOZOLOMIDE + RT | 100700323 |
| 220002032 | 220008467 | null | null | null | null | 2021-11-08 | null | 02 | null | LOMUSTINE + PROCARBAZINE + VINCRISTINE | 100314025 |
| 220002036 | 220008468 | null | null | null | null | 2017-11-09 | Epirubicin (weekly) | null | null | PEMBROLIZUMAB | 101085117 |
| 220002039 | 220008470 | null | null | null | 2019-09-15 | 2019-09-22 | null | 02 | null | TEMOZOLOMIDE + RT | 101747784 |
| 220002048 | 220008475 | null | null | null | null | 2019-10-07 | null | null | null | CNS LGG 2004 03 VINC WEEKLY+ CARBO | 101081306 |
| 220002051 | 220008477 | 1.72 | 73.55 | null | null | 2016-10-15 | CNS Low Grade Glioma Vinblastine | null | null | TRIAL UNSPECIFIED | 101525499 |
| 220002060 | 220008481 | 1.72 | 82.8 | null | null | 2018-02-01 | Trial Unspecified | null | null | VINBLASTINE | 100785448 |
| 220002064 | 220008484 | null | null | null | null | 2019-12-22 | PCV | null | null | DABRAFENIB + TRAMETINIB | 101579884 |
| 220002103 | 220008504 | 1.73 | 57.4 | null | null | 2019-04-21 | NIVOLUMAB | null | null | LOMUSTINE + PROCARBAZINE + VINCRISTINE | 101750535 |
| 220002122 | 220008506 | null | null | null | null | 2019-12-27 | CNS HGG Temozolomide maintenance | null | null | LOMUSTINE + PROCARBAZINE + VINCRISTINE | 101374510 |
| 220002154 | 220008512 | null | null | null | null | 2017-09-15 | PCV | null | null | CNS LGG 2004 03 VINC WEEKLY+ CARBO | 101290423 |
| 220002160 | 220008514 | 1.52 | 98.7 | null | 2019-05-31 | 2019-06-18 | null | 02 | null | CNS INFANT HGG VINCRISTINE/CYCLOPHOSPHAMIDE | 101640756 |
| 220002167 | 220008517 | null | null | null | 2019-12-01 | 2019-12-02 | PCV | 02 | null | CNS LGG 2004 03 VINC WEEKLY+ CARBO | 100787047 |
| 220002169 | 220008518 | 1.69 | 93.4 | null | null | 2017-03-28 | null | null | null | CARBOPLATIN + VINCRISTINE | 101221444 |
| 220002179 | 220008520 | null | null | null | null | 2016-03-10 | null | null | null | DABRAFENIB + TRAMETINIB | 100382267 |
| 220002211 | 220008528 | null | null | 03 | 2016-11-24 | 2016-11-24 | null | 02 | N | LOMUSTINE + PROCARBAZINE + VINCRISTINE | 100667906 |
| 220002226 | 220008534 | 1.18 | 63 | null | null | 2018-05-29 | null | null | null | TEMOZOLOMIDE + RT | 101068444 |
| 220002245 | 220008540 | null | null | null | null | 2016-12-07 | null | null | null | CRIZOTINIB | 100605703 |
| 220002252 | 220008543 | null | null | null | null | 2017-11-11 | null | null | null | LOMUSTINE | 101734338 |
| 220002271 | 220008550 | null | null | Palliative (P) | 2019-08-31 | 2019-09-11 | DABRAFENIB + TRAMETINIB | 02 | N | CNS LGG2004 03 VINC + CARBO | 101794027 |
| 220002284 | 220008552 | 1.59 | 78.5 | null | null | 2018-12-27 | PCV | null | null | LOMUSTINE + PROCARBAZINE + VINCRISTINE | 100924742 |
| 220002313 | 220008563 | 1.63 | 107.6 | null | null | 2018-02-21 | null | null | null | TRIAL UNSPECIFIED | 101680625 |
| 220002315 | 220008565 | null | null | null | null | 2017-09-08 | null | null | null | CNS EPENDY II VINC/CARBO | 101597685 |
| 220002316 | 220008566 | null | null | Palliative (P) | 2016-06-14 | 2016-07-01 | Temozolomide + RT | 02 | N | DABRAFENIB + TRAMETINIB | 100322423 |
| 220002318 | 220008567 | null | null | Palliative (P) | 2017-06-26 | 2017-06-26 | Trial Unspecified | 02 | N | LOMUSTINE + PROCARBAZINE + VINCRISTINE | 100211654 |
| 220002324 | 220008569 | null | null | Palliative (P) | 2017-09-27 | 2017-10-25 | CARBOPLATIN + VINCRISTINE | 02 | N | TEMOZOLOMIDE + RT | 100123651 |
| 220002325 | 220008570 | null | null | Adjuvant (A) | 2020-01-20 | 2020-01-20 | PCV | 02 | Y | LOMUSTINE + PROCARBAZINE + VINCRISTINE | 100837207 |
| 220002327 | 220008572 | 1.69 | 18.2 | Curative (C) | 2017-05-15 | 2017-05-27 | CNS Medbl HR Carboplatin/Vinc/Cyclophos/GCSF | 02 | N | LOMUSTINE + PROCARBAZINE + VINCRISTINE | 100665222 |
| 220002363 | 220008584 | 1.78 | 83.1 | null | null | 2017-07-18 | Lomustine | null | null | LOMUSTINE | 101538547 |